By Jennifer Hinkel, NCCN e-Bulletin Editor-in-Chief
In December, a group of cancer center administrators and oncologists will travel from their home institutions in China to visit and learn at the NCCN Member Institutions in the United States. Over the course of several days, the visitors will meet with faculty, administrators, and NCCN leadership in New York, NY, Fort Washington, PA, and Baltimore, MD to discuss both the latest science and evidence in oncology and the differences between oncology practice in the United States and China. As part of the program, the visitors will participate in site visits of Memorial Sloan-Kettering Cancer Center in New York, NY, and The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. This is the most recent and most distinguished delegation of Chinese cancer center administrators and clinical experts to visit the United States as part of the NCCN Global Leadership Exchange program.
“This program provides a valuable platform for exchange of knowledge and experience among leaders in cancer care in the United States and China,” said William T. McGivney, PhD, Chief Executive Officer, NCCN. “As the NCCN Guidelines become more widely distributed and accepted worldwide, we are finding more opportunities to engage in a global conversation about how to best deliver cancer care around the world.”
The Global Leadership Exchange program is only one example of NCCN's efforts to bring its information to a wider audience internationally. For example, the NCCN 2nd Annual Asia Scientific Congress, held in Beijing, Shanghai, and Guangzhou, China, attracted more than 3,000 delegates. As part of that Congress, NCCN Guidelines Panel Members and invited clinical experts from Asia held consensus discussions to develop Asia Consensus Statements, which include scientific descriptions and analyses of variations in cancer care across numerous regions within Asia. In 2009, NCCN programs were also held in Abu Dhabi, United Arab Emirates; and Tokyo and Yokohama, Japan. In December of 2009, NCCN will hold a program in Seoul, South Korea.
Along with demand for such international educational programs, demand for the development and publication of foreign editions of the NCCN Guidelines has also grown. In 2009, NCCN approved China Editions of the Guidelines for Breast Cancer, Cervical Cancer, Colon Cancer, Gastric Cancer, Head & Neck Cancers, Kidney Cancer, Non-Hodgkin's Lymphomas, Non-Small Cell Lung Cancer, Ovarian Cancer, and Rectal Cancer. In 2010, NCCN plans to approve publication of Korea Editions of the Breast Cancer and Rectal Cancer Guidelines. Additionally, NCCN has agreed to the translation of the Complete Library of NCCN Guidelines into the Japanese language without adaptation by a major, national university in Kyoto, Japan.